Literature DB >> 15814971

Determinants for the occurrence of acute exacerbation of hepatitis B virus infection in Chinese patients after HBeAg seroclearance.

He-Jun Yuan1, Man-Fung Yuen, Danny Ka-Ho Wong, Siu-Man Sum, Joke Doutreloigne, Erwin Sablon, Ching-Lung Lai.   

Abstract

This study was performed to determine the factors for predicting the occurrence of acute exacerbation of hepatitis B virus infection in HBeAg-negative patients. Two hundred and sixteen patients with known times of HBeAg seroclearance were recruited. Liver biochemistry and virologic markers were monitored. Precore and core promoter mutations were determined by a line probe assay. The median age at HBeAg seroclearance was 34.5 years. The median follow-up duration was 26.4 months. Fifty-six (27.9%) patients had acute exacerbations. By Cox regression analysis, male gender, older age, and core promoter mutations at the time of HBeAg seroclearance were independently associated with the occurrence of acute exacerbation after HBeAg seroclearance (P = 0.025, 0.018, and 0.001, respectively). Fourteen (7.0%) patients had HBeAg seroreversion within a median follow-up period of 11.6 months after HBeAg seroclearance. By Cox regression analysis, older age at HBeAg seroclearance was independently associated with the chance of HBeAg seroreversion (P = 0.01). We concluded that male patients with core promoter mutations and delayed HBeAg seroclearance had a higher cumulative chance of acute exacerbation in the HBeAg-negative phase. Patients with delayed HBeAg seroclearance had a higher frequency of HBeAg seroreversion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15814971      PMCID: PMC1081372          DOI: 10.1128/JCM.43.4.1594-1599.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

1.  Chronic hepatitis B.

Authors:  A S Lok; B J McMahon
Journal:  Hepatology       Date:  2001-12       Impact factor: 17.425

2.  Relationship between the development of precore and core promoter mutations and hepatitis B e antigen seroconversion in patients with chronic hepatitis B virus.

Authors:  Man-Fung Yuen; Erwin Sablon; He-Jun Yuan; Chee-Kin Hui; Danny Ka-Ho Wong; Joke Doutreloigne; Benjamin Chun-Yu Wong; Annie On-On Chan; Ching-Lung Lai
Journal:  J Infect Dis       Date:  2002-10-11       Impact factor: 5.226

3.  Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications.

Authors:  M F Yuen; C K Hui; C C Cheng; C H Wu; Y P Lai; C L Lai
Journal:  Hepatology       Date:  2001-07       Impact factor: 17.425

Review 4.  Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease.

Authors:  R P Perrillo
Journal:  Gastroenterology       Date:  2001-03       Impact factor: 22.682

Review 5.  Diagnosis and management of pre-core mutant chronic hepatitis B.

Authors:  G V Papatheodoridis; S J Hadziyannis
Journal:  J Viral Hepat       Date:  2001-09       Impact factor: 3.728

6.  Natural history of chronic hepatitis B virus infection.

Authors:  M F Yuen; C L Lai
Journal:  J Gastroenterol Hepatol       Date:  2000-05       Impact factor: 4.029

7.  A large population study of spontaneous HBeAg seroconversion and acute exacerbation of chronic hepatitis B infection: implications for antiviral therapy.

Authors:  M-F Yuen; H-J Yuan; C-K Hui; D K-H Wong; W-M Wong; A O-O Chan; B C-Y Wong; C-L Lai
Journal:  Gut       Date:  2003-03       Impact factor: 23.059

Review 8.  Immunopathogenesis of hepatitis B e antigen negative chronic hepatitis B infection.

Authors:  S J Hadziyannis; D Vassilopoulos
Journal:  Antiviral Res       Date:  2001-11       Impact factor: 5.970

9.  Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study.

Authors:  Maurizia Rossana Brunetto; Filippo Oliveri; Barbara Coco; Gioacchino Leandro; Piero Colombatto; Juliana Monti Gorin; Ferruccio Bonino
Journal:  J Hepatol       Date:  2002-02       Impact factor: 25.083

10.  The significance of spontaneous hepatitis B e antigen seroconversion in childhood: with special emphasis on the clearance of hepatitis B e antigen before 3 years of age.

Authors:  M H Chang; H Y Hsu; H C Hsu; Y H Ni; J S Chen; D S Chen
Journal:  Hepatology       Date:  1995-11       Impact factor: 17.425

View more
  2 in total

Review 1.  Acute exacerbation of chronic hepatitis B: the dilemma of differentiation from acute viral hepatitis B.

Authors:  Pankaj Puri
Journal:  J Clin Exp Hepatol       Date:  2013-10-17

Review 2.  Chronic Hepatitis B with Spontaneous Severe Acute Exacerbation.

Authors:  Wei-Lun Tsai; Wei-Chi Sun; Jin-Shiung Cheng
Journal:  Int J Mol Sci       Date:  2015-11-26       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.